Panel: Rethinking Platform Biotech - How Emerging Innovators Are Structuring the Future of Pharma Collaboration

Session details:

Platform biotech companies are reshaping pharma’s innovation model - but getting deals done requires more than breakthrough science. In this session, leaders from emerging platform companies share hard-earned lessons from the dealmaking front lines. Alongside pharma perspective, they’ll unpack how they framed value, navigated control, and structured partnerships to preserve upside while building long-term credibility.

• Hear how platform biotechs are proving value beyond a single asset—and what that means for deal design
• Learn how companies approach optionality, equity stakes, and governance to align short-term needs with long-term vision
• Understand what biotechs wish pharma understood better when it comes to platform risk, valuation, and partnership expectations